[{"question": "Etanercept is a disease-modifying drug used in management of rheumatoid ahritis. What is its mechanism of action?", "correct_answer": "IL-6 inhibition", "options": ["A)COX-2 inhibition", "B)Inhibition of TNF alpha", "C)Stabilization of mast cells", "D)IL-6 inhibition"], "prompt": "\n\nQ:Etanercept is a disease-modifying drug used in management of rheumatoid ahritis. What is its mechanism of action?A)COX-2 inhibition B)Inhibition of TNF alpha C)Stabilization of mast cells D)IL-6 inhibition\n\nA:", "output1": "\n<bot>: Etanercept is a soluble decoy receptor that inhibits the activity of TNF-alpha by binding to it and preventing it from binding to its native receptors. This inhibition of TNF-alpha activity leads to a reduction in the production of prostaglandins, which are pro-inflammatory mediators that are involved in the pathogenesis of rheumatoid arthritis.\n\n", "output2": "\n\n", "output3": "\n\n", "output4": "\n<bot>: Etanercept is a soluble decoy receptor that binds to IL-6 and prevents its interaction with the IL-6 receptor, thus inhibiting the IL-6 signaling pathway.\n\n"}, {"question": "Phase_____trial is used to signify the integration of a new clinical treatment into widespread public health practice?", "correct_answer": "Phase 4", "options": ["A)Phase 4", "B)Phase 2", "C)Phase 1", "D)Phase 5"], "prompt": "\n\nQ:Phase_____trial is used to signify the integration of a new clinical treatment into widespread public health practice?A)Phase 4 B)Phase 2 C)Phase 1 D)Phase 5\n\nA:", "output1": "\n<bot>: Phase 4 trials are designed to evaluate the effectiveness and safety of a new treatment in a larger, more diverse population, and to monitor the treatment's use in real-world clinical practice. This is the final phase of clinical trials before a treatment is considered for approval by regulatory authorities.\n\n", "output2": "\n<bot>: Phase 2 trials are designed to evaluate the safety and efficacy of a new treatment in a larger, more diverse group of patients. This is typically done after Phase 1 trials have shown promise, and before Phase 3 trials, which are conducted to confirm the treatment's effectiveness and prepare it for widespread use. Phase 2 trials are an important step in the drug development process, and their results can help determine whether a treatment is worthy of further study and eventual approval by regulatory authorities.", "output3": "\n<bot>: Phase 1 trials are conducted to assess the safety and tolerability of a new drug or treatment in a small number of healthy volunteers. Once the drug or treatment is deemed safe and well-tolerated, it can move on to larger, more extensive clinical trials in Phase 2 and 3. Phase 4 trials, on the other hand, are used to monitor the safety and efficacy of a drug or treatment after it has been approved and released to the public. Therefore, Phase 1 trials are the first step in the process of integrating a new clinical treatment into widespread public health practice, making C the correct answer.\n\n", "output4": "\n<bot>: Phase 5 trials are conducted after a new treatment has been approved by regulatory authorities and is being widely used in clinical practice. At this point, the treatment is considered to be well-established and its safety and efficacy have been confirmed. The purpose of Phase 5 trials is to further evaluate the treatment's effectiveness and monitor its safety in real-world settings.\n<human>"}, {"question": "Which is not related to HIV", "correct_answer": "Primary CNS lymphoma", "options": ["A)Teiary syphilis", "B)None", "C)Primary CNS lymphoma", "D)Oesophageal candidasis"], "prompt": "\n\nQ:Which is not related to HIVA)Teiary syphilis B)None C)Primary CNS lymphoma D)Oesophageal candidasis\n\nA:", "output1": "\n<bot>: Teiary syphilis is not related to HIV, as it is a stage of syphilis that occurs before the onset of HIV infection. The other options are all related to HIV: primary CNS lymphoma is a type of cancer that affects the brain and is associated with HIV, oesophageal candidiasis is a type of opportunistic infection that is more common in people with HIV, and none of the above is a statement that is not related to HIV.\n\n", "output2": "\n<bot>: Because there is no relationship between HIV and any of the other options.\n\n", "output3": "\n<bot>: Because primary CNS lymphoma is not related to HIV. The other options are all opportunistic infections that can occur in people with HIV.\n\n", "output4": "\n<bot>: Because oesophageal candidiasis is not related to HIV. The other options are all potential complications of HIV infection.\n\n"}, {"question": "Metamorphopsia is seen in ?", "correct_answer": "Anterior uveitis", "options": ["A)Posterior uveitis", "B)Cataract", "C)Anterior uveitis", "D)Glaucoma"], "prompt": "\n\nQ:Metamorphopsia is seen in ?A)Posterior uveitis B)Cataract C)Anterior uveitis D)Glaucoma\n\nA:", "output1": "\n<bot>: Metamorphopsia is a visual symptom caused by inflammation in the posterior segment of the eye, which can occur in posterior uveitis. It is not typically seen in cataract, anterior uveitis, or glaucoma.\n\n", "output2": "\n<bot>: Metamorphopsia is a symptom of cataract. It is characterized by the appearance of distorted or altered vision, such as seeing wavy lines or shapes. Cataract is a clouding of the lens in the eye that can cause vision problems, including metamorphopsia.\n\n", "output3": "\n<bot>: Metamorphopsia is a symptom of anterior uveitis, which is an inflammation of the iris and ciliary body. It is characterized by distorted vision, including seeing geometric shapes as wavy or curved lines.\n\n", "output4": "\n<bot>: Metamorphopsia is a symptom of glaucoma, which is a group of eye conditions that can damage the optic nerve and lead to vision loss. It is characterized by distorted vision, including seeing wavy lines or shapes.\n\n"}, {"question": "A 49-year-old woman presents to her pulmonologist for a follow-up visit. She reports a longstanding history of chronic dyspnea and fatigue. Her past medical history is notable for asthma. She has a known mutation in the BMPR2 gene. She was recently trialed on nifedipine but stopped due to severe lower extremity edema. She does not smoke and does not drink alcohol. Her temperature is 99.4\u00b0F (37.4\u00b0C), blood pressure is 135/80 mmHg, pulse is 80/min, and respirations are 20/min. Physical examination reveals an increased P2 on cardiac auscultation. Her physician recommends starting a medication to slow the patient\u2019s clinical worsening that requires regular monitoring of liver function tests. This medication has which of the following mechanisms of action?", "correct_answer": "Beta-2-adrenergic receptor agonist", "options": ["A)Endothelin-1 receptor antagonist", "B)Phosphodiesterase type 5 antagonist", "C)Beta-2-adrenergic receptor agonist", "D)Phospholipase A2 antagonist"], "prompt": "\n\nQ:A 49-year-old woman presents to her pulmonologist for a follow-up visit. She reports a longstanding history of chronic dyspnea and fatigue. Her past medical history is notable for asthma. She has a known mutation in the BMPR2 gene. She was recently trialed on nifedipine but stopped due to severe lower extremity edema. She does not smoke and does not drink alcohol. Her temperature is 99.4\u00b0F (37.4\u00b0C), blood pressure is 135/80 mmHg, pulse is 80/min, and respirations are 20/min. Physical examination reveals an increased P2 on cardiac auscultation. Her physician recommends starting a medication to slow the patient\u2019s clinical worsening that requires regular monitoring of liver function tests. This medication has which of the following mechanisms of action?A)Endothelin-1 receptor antagonist B)Phosphodiesterase type 5 antagonist C)Beta-2-adrenergic receptor agonist D)Phospholipase A2 antagonist\n\nA:", "output1": "\n<bot>: The patient has a known mutation in the BMPR2 gene, which is associated with pulmonary arterial hypertension (PAH). Endothelin-1 (ET-1) is a potent vasoconstrictor that is elevated in PAH. An ET-1 receptor antagonist, such as bosentan, can help to reduce the severity of PAH by blocking the actions of ET-1 on the endothelium.\n\n", "output2": "\n<bot>: The patient has a known mutation in the BMPR2 gene, which is associated with pulmonary hypertension. The BMPR2 gene encodes a receptor for bone morphogenetic protein 2 (BMP2), which is involved in the regulation of pulmonary vascular tone. Phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, work by increasing the levels of cyclic guanosine monophosphate (cGMP), which in turn can decrease pulmonary vascular resistance and improve exercise capacity.\n\n", "output3": "\n<bot>: The patient has a known mutation in the BMPR2 gene, which is associated with pulmonary hypertension. Beta-2-adrenergic receptor agonists, such as formoterol, have been shown to improve exercise capacity and reduce symptoms in patients with pulmonary hypertension. Additionally, beta-2-adrenergic receptor agonists can improve lung function and reduce inflammation in patients with asthma, which is also a comorbidity in this patient.\n\n", "output4": "\n<bot>: The patient has a known mutation in the BMPR2 gene, which is associated with pulmonary arterial hypertension (PAH). This medication, a phospholipase A2 antagonist, is used to treat PAH by reducing the activity of phospholipase A2, an enzyme that contributes to the development of pulmonary vascular remodeling.\n\n"}, {"question": "Prolactin secreted maximum at-", "correct_answer": "24 hour after Ovulation", "options": ["A)2 hrs running", "B)24 hour after Ovulation", "C)REM", "D)24 hrs after delivery"], "prompt": "\n\nQ:Prolactin secreted maximum at-A)2 hrs running B)24 hour after Ovulation C)REM D)24 hrs after delivery\n\nA:", "output1": "\n<bot>: Prolactin secretion is stimulated by exercise, specifically running, and the highest levels are reached 2 hours after running.\n\n", "output2": "\n<bot>: Prolactin is a hormone that is secreted by the pituitary gland and plays a role in the regulation of lactation and other physiological processes. It is secreted in response to sexual stimulation and reaches its maximum level 24 hours after ovulation, when the body is preparing for pregnancy.\n\n", "output3": "\n<bot>: Prolactin is a hormone that stimulates milk production in lactating females. Its secretion is triggered by the hypothalamus during REM sleep, which is why it is highest during this stage.\n\n", "output4": "\n<bot>: Prolactin is a hormone that stimulates milk production in lactating women. Its secretion is maximal 24 hours after delivery to help the breast tissue prepare for lactation.\n\n"}, {"question": "Statements about hostility (hostility) and coronary heart disease, which of the following error?", "correct_answer": "Hostility is the core component of type A behavior", "options": ["A)Hostility is the core component of type A behavior", "B)Myocardial infarction patients were group psychotherapy to improve their Type A behavior, can effectively reduce mortality and reinfarction rate", "C)Hostility promotes parasympathetic function", "D)According to patterns of behavior theory, A-type behavior (type A behavior) represents irritability, impatience, impatient, associated with the incidence of myocardial infarction and coronary heart disease"], "prompt": "\n\nQ:Statements about hostility (hostility) and coronary heart disease, which of the following error?A)Hostility is the core component of type A behavior B)Myocardial infarction patients were group psychotherapy to improve their Type A behavior, can effectively reduce mortality and reinfarction rate C)Hostility promotes parasympathetic function D)According to patterns of behavior theory, A-type behavior (type A behavior) represents irritability, impatience, impatient, associated with the incidence of myocardial infarction and coronary heart disease\n\nA:", "output1": "\n\n", "output2": "\n<bot>: Because the statement \"Myocardial infarction patients were group psychotherapy to improve their Type A behavior, can effectively reduce mortality and reinfarction rate\" is a statement about the relationship between hostility and coronary heart disease, and it is not a statement about the core component of type A behavior.\n\n", "output3": "\n<bot> A: Because hostility can activate the body's \"fight or flight\" response, which is mediated by the sympathetic nervous system. This can lead to an increase in heart rate, blood pressure, and other physiological responses that may be harmful to the cardiovascular system. In contrast, the parasympathetic nervous system is responsible for promoting relaxation and reducing stress, which can have a protective effect on the heart and blood vessels.\n\n", "output4": "\n<bot>: Because the statement \"Hostility promotes parasympathetic function\" is not accurate. Hostility is a behavior pattern, not a physiological function. The parasympathetic nervous system is a part of the autonomic nervous system that promotes relaxation and reduces stress, but it is not directly related to hostility.\n<human>"}, {"question": "A dental disturbance that has a greater psychological impact on both the parents and child is", "correct_answer": "Multiple decayed teeth", "options": ["A)Discolored front tooth", "B)Fracture or loss of an anterior tooth", "C)Mucocele", "D)Multiple decayed teeth"], "prompt": "\n\nQ:A dental disturbance that has a greater psychological impact on both the parents and child isA)Discolored front tooth B)Fracture or loss of an anterior tooth C)Mucocele D)Multiple decayed teeth\n\nA:", "output1": "\n<bot>: A discolored front tooth can have a greater psychological impact on both the parents and child because it is more visible and can be a source of embarrassment or self-consciousness for the child. Additionally, the front teeth are often associated with appearance and are a key aspect of a person's smile, so a discolored or missing front tooth can be more noticeable and have a greater impact on the child's self-esteem.\n\n", "output2": "\n<bot>: A fracture or loss of an anterior tooth can have a greater psychological impact on both the parents and child because it can affect the child's self-esteem and confidence, and also the way they look and feel about themselves.\n\n", "output3": "\n<bot> A: Because a mucocele is a benign growth of mucous membranes that can be unsightly and cause emotional distress, especially in children.\n\n", "output4": "\n\n"}, {"question": "True about oral iron preparations ?", "correct_answer": "Most commonly used preparation is ferrous gluconate", "options": ["A)Ferric preparations are more effective", "B)Most commonly used preparation is ferrous gluconate", "C)Different preparations have different biovailability", "D)Ferrous fumarate is most efficient"], "prompt": "\n\nQ:True about oral iron preparations ?A)Ferric preparations are more effective B)Most commonly used preparation is ferrous gluconate C)Different preparations have different biovailability D)Ferrous fumarate is most efficient\n\nA:", "output1": "\n<bot>: Because ferric iron is more readily absorbed by the body than ferrous iron.\n<human>", "output2": "A)Because it is cheaper to produce than other preparationsB)It is more easily absorbed by the bodyC)It is less likely to cause gastrointestinal side effectsD)It is more effective at treating anemia\n\n", "output3": "\n<bot>: Because the bioavailability of oral iron preparations can vary depending on the formulation and the dose. Ferrous gluconate, for example, has a higher bioavailability than ferrous sulfate, but ferrous fumarate has a lower bioavailability than ferrous gluconate.\n<human>", "output4": "\n<bot> A: Ferrous fumarate has the highest bioavailability among all oral iron preparations, which means it is best absorbed by the body.\n\n"}, {"question": "Under ESI act, the state government's share of expenditure on medical care is?", "correct_answer": "2/3rd", "options": ["A)1/4th", "B)1/8th", "C)2/3rd", "D)2-Jan"], "prompt": "\n\nQ:Under ESI act, the state government's share of expenditure on medical care is?A)1/4th B)1/8th C)2/3rd D)2-Jan\n\nA:", "output1": "\n<bot>: Under the ESI Act, the state government's share of expenditure on medical care is 1/4th of the total expenditure.\n\n", "output2": "\n<bot>: Under the ESI Act, the state government's share of expenditure on medical care is 1/8th because the Act provides for a shared funding mechanism between the central and state governments. The central government contributes 1/4th of the total expenditure, while the state governments contribute 1/8th.\n\n", "output3": "\n<bot>: Under the ESI Act, the state government's share of expenditure on medical care is 2/3rd of the total expenditure.\n\n", "output4": "\n\n"}]